Abstract:Background: High-throughput sequencing has rapidly become an essential part of precision cancer medicine. But validating results obtained from analyzing and interpreting genomic data remains a rate-limiting factor. The gold standard, of course, remains manual validation by expert panels, which is not without its weaknesses, namely high costs in both funding and time as well as the necessarily selective nature of manual validation. But it may be possible to develop more economical, complementary means of validation. In this study we employed four synthetic data sets (variants with known mutations spiked into specific genomic locations) of increasing complexity to assess the sensitivity, specificity, and balanced accuracy of five open-source variant callers: FreeBayes v1.0, VarDict v11.5.1, MuTect v1.1.7, MuTect2, and MuSE v1.0rc. FreeBayes, VarDict, and MuTect were run in bcbio-next gen, and the results were integrated into a single Ensemble call set. The known mutations provided a level of "ground truth" against which we evaluated variant-caller performance. We further facilitated the comparison and evaluation by segmenting the whole genome into 10,000,000 base-pair fragments which yielded 316 segments. Results: Differences among the numbers of true positives were small among the callers, but the numbers of false positives varied much more when the tools were used to analyze sets one through three. Both FreeBayes and VarDict produced strikingly more false positives than did the others, although VarDict, somewhat paradoxically also produced the highest number of true positives. The Ensemble approach yielded results characterized by higher specificity and balanced accuracy and fewer false positives than did any of the five tools used alone. Sensitivity and specificity, however, declined for all five callers as the complexity of the data sets increased, but we did not uncover anything more than limited, weak correlations between caller performance and certain DNA structural features: gene density and guanine-cytosine content. Altogether, MuTect2 performed the best among the callers tested, followed by MuSE and MuTect. Conclusions: Spiking data sets with specific mutations -single-nucleotide variations (SNVs), single-nucleotide polymorphisms (SNPs), or structural variations (SVs) in this study-at known locations in the genome provides an effective and economical way to compare data analyzed by variant callers with ground truth. The method constitutes a viable alternative to the prolonged, expensive, and noncomprehensive assessment by expert panels. It should be further developed and refined, as should other comparatively "lightweight" methods of assessing accuracy. Given that the scientific community has not yet established gold standards for validating NGS-related technologies such as variant callers, developing multiple alternative means for verifying variant-caller accuracy will eventually lead to the establishment of higher-quality standards than could be achieved by prematurely limiting the range of innovative methods explored by members of the community.

Comparison of somatic mutation calling tools for second generation sequencing

Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers

Next Generation Sequencing Technology and Its Application in Detecting Gene Mutations

In-Depth Comparison of Somatic Point Mutation Callers Based on Different Tumor Next-Generation Sequencing Depth Data

Towards an Accurate and Robust Analysis Pipeline for Somatic Mutation Calling

Comparing the performance of selected variant callers using synthetic data and genome segmentation

Comprehensive Assessment of Somatic Copy Number Variation Calling Using Next-Generation Sequencing Data

Systematic comparison of variant calling pipelines of target genome sequencing cross multiple next-generation sequencers

Benchmarking variant callers in next-generation and third-generation sequencing analysis

Abstract P19: Comprehensive Benchmark of Somatic Mutation Callers on Cell-Free DNA Next-Generation Sequencing Data in Cancer Liquid Biopsy

Statistical Methods For The Analysis Of Next Generation Sequencing Data From Paired Tumor-Normal Samples

Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing

Somatic Point Mutation Calling in Low Cellularity Tumors

Evaluation of somatic copy number variation detection by NGS technologies and bioinformatics tools on a hyper-diploid cancer genome

Comparison of Three Commercial Decision Support Platforms for Matching of Next-Generation Sequencing Results with Therapies in Patients with Cancer

Accelerated somatic mutation calling for whole-genome and whole-exome sequencing data from heterogenous tumor samples

Systematic Comparative Analysis of Single-Nucleotide Variant Detection Methods from Single-Cell RNA Sequencing Data

An evaluation of copy number variation detection tools from whole-exome sequencing data.

Systematic evaluation of de novo mutation calling tools using whole genome sequencing data

Detecting Somatic Mutations Without Matched Normal Samples Using Long Reads

Evaluation of Somatic Copy Number Estimation Tools for Whole-Exome Sequencing Data